Image

Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance

Recruiting
18 - 45 years of age
Female
Phase N/A

Powered by AI

Overview

This study will test the hypothesis that the molecular changes present in ectopic endometriosis lesions correlate with progesterone-resistant disease (using the criteria defined in this study) and are present in matched eutopic endometrium.

Description

Tissues from 100 patients with endometriosis will be analyzed with droplet digital PCR (ddPCR) targeted sequencing and responders (n=50) will be compared to non-responders (n=50) after controlling confounding factors.

From a subset of the 100 cases, whole exome sequencing (WES) and Methylation-Specific PCR (MSP)-based methylation profiling on microdissected epithelium and stroma will be performed in matched eutopic and ectopic tissues from 20 patients with known cancer-associated mutations or 20 controls.

Eligibility

Inclusion Criteria:

  • Signed informed consent.
  • Gender: female.
  • Age: 18-45 years at the time of signing consent.
  • Clinical or surgical diagnosis of endometriosis undergoing laparoscopy.
  • Controls may not have clinical or surgical diagnosis of endometriosis.
  • Regular menstrual cycles.
  • BMI between 18-40 kg/m2.
  • Sexually active or have had a previous vaginal exam that used a speculum.
  • English speaking

Exclusion Criteria:

  • Use of any kind of steroidal therapy including oral contraceptives, Norplant, estrogen replacement/supplemental therapy, androgens (Danazol, Cyclomen, Danocrine, testosterone) or progesterone. She may not be taking or be on Celebrex.
  • Pregnant.
  • Presence of pelvic infection.
  • Mullerian anomalies with absence of a cervix.
  • History of cancer of the reproductive tract.
  • Presence of undiagnosed uterine bleeding.
  • Treatment with intrauterine device (IUD) or progestin-containing intrauterine device.

Study details

Endometriosis, Endometrial Diseases

NCT03756480

Johns Hopkins University

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.